Pallas Capital Advisors LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1862282 BRAINTREE, MA

Position in ALNY

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$663,169

-$68,715 QoQ

Shares Held

2,203

-0.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#452

of 786 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 17% Shared 0% None 83%

Healthcare · as of Jun 30, 2026

Pallas Capital Advisors LLC holds $30,351,010 across 36 Biotechnology names. ALNY ranks #8 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	40,511	$9,915,877
2	RPRX	Royalty Pharma plc	108,585	$6,088,360
3	INCY	Incyte Corp	32,151	$3,644,637
4	EXEL	Exelixis, Inc.	30,721	$1,671,529
5	REGN	Regeneron Pharmaceuticals, Inc.	1,920	$1,197,196
6	VRTX	Vertex Pharmaceuticals Inc / Ma	2,200	$1,092,806
7	FTRE	Fortrea Holdings Inc.	39,499	$687,282
8	ALNY	Alnylam Pharmaceuticals, Inc. This page	2,203	$663,169

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$663,169	2,203	-0.4%	Shares	Sole	2026-08-07
2026-03-31	$731,884	2,212	-46.2%	Shares	Sole	2026-04-21
2025-12-31	$1,633,943	4,109	-7.1%	Shares	Sole	2026-01-14
2025-09-30	$2,017,800	4,425	+72.2%	Shares	Sole	2025-11-07
2025-06-30	$838,051	2,570	-61.3%	Shares	Sole	2025-07-09
2025-03-31	$1,791,582	6,635	+94.7%	Shares	Sole	2025-04-14
2024-12-31	$801,936	3,408	+2.6%	Shares	Sole	2025-01-13
2024-09-30	$913,374	3,321	+61.8%	Shares	Sole	2024-10-25
2024-06-30	$498,636	2,052	—	Shares	Sole	2024-07-22
No filing history on record for this holder in this stock.